Management of Oncology Care in Urology Practices

Video

In the last decade, there has been a rapid expansion in the number of oncolytic therapies and a consolidation of independent urology practices with an ever-growing number of large groups forming in urban settings across the United States. As a result, the urologic practice community has become more involved in the treatment of advanced cancer patients.

Addressing the larger issue of urology practice management, the panel discusses how urology practice models may affect patient care. Panelists E. David Crawford, MD, and Mark S. Austenfeld, MD, agree that a multidisciplinary approach is needed that incorporates medical oncology, radiation oncology, pathology, and imaging in addition to specialized centers for bone health and infusions.

Neal D. Shore, MD, believes a large urology groups in the community may follow the multidisciplinary academic models as describe by Crawford and Austenfeld, but practice size allows these groups to be more facile and nimble in understanding new therapeutics, especially in oncology and urology. Paul R. Sieber, MD, adds that as urology practices grow and new specialties are added the biggest challenge is providing uniform care across the entire practice.

Related Videos
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Samer A. Srour, MB ChB, MS
Scott T. Tagawa, MD, MS, FACP, FASCO
Carmen Guerra, MD, MSCE, FACP
Kara N. Maxwell, MD, PhD
Josep Maria Piulats Rodriguez, MD, PhD
Samer A. Srour, MB ChB, MS
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
Phillip J. Koo, MD